Abstract:Motivation: Emerging evidence presents that traditional drug discovery experiment is time-consuming and high costs. Computational drug repositioning plays a critical role in saving time and resources for drug research and discovery. Therefore, developing more accurate and efficient approaches is imperative. Heterogeneous graph inference is a classical method in computational drug repositioning, which not only has high convergence precision, but also has fast convergence speed. However, the method has not fully considered the sparsity of heterogeneous association network. In addition, rough similarity measure can reduce the performance in identifying drug-associated indications. Results: In this article, we propose a heterogeneous graph inference with matrix completion (HGIMC) method to predict potential indications for approved and novel drugs. First, we use a bounded matrix completion (BMC) model to prefill a part of the missing entries in original drug-disease association matrix. This step can add more positive and formative drug-disease edges between drug network and disease network. Second, Gaussian radial basis function (GRB) is employed to improve the drug and disease similarities since the performance of heterogeneous graph inference more relies on similarity measures. Next, based on the updated drug-disease associations and new similarity measures of drug and disease, we construct a novel heterogeneous drug-disease network. Finally, HGIMC utilizes the heterogeneous network to infer the scores of unknown association pairs, and then recommend the promising indications for drugs. To evaluate the performance of our method, HGIMC is compared with five state-of-the-art approaches of drug repositioning in the 10-fold cross-validation and de novo tests. As the numerical results shown, HGIMC not only achieves a better prediction performance but also has an excellent computation efficiency. In addition, cases studies also confirm the effectiveness of our method in practical application.

A Novel Graph Representation Learning Model for Drug Repositioning Using Graph Transition Probability Matrix over Heterogenous Information Networks.

Drug repositioning based on weighted local information augmented graph neural network

Drug Repositioning by Collaborative Learning Based on Graph Convolutional Inductive Network

Relation-aware Heterogeneous Graph Transformer Based Drug Repurposing

Drug repositioning based on the heterogeneous information fusion graph convolutional network

Drug repositioning with adaptive graph convolutional networks

Regulation-aware graph learning for drug repositioning over heterogeneous biological network

Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning

Attention Transfer in Heterogeneous Networks Fusion for Drug Repositioning

Drug Repositioning Via Multi-view Representation Learning with Heterogeneous Graph Neural Network

A geometric deep learning framework for drug repositioning over heterogeneous information networks

Drug repositioning based on heterogeneous networks and variational graph autoencoders

Drug Repositioning by Multi-Aspect Heterogeneous Graph Contrastive Learning and Positive-Fusion Negative Sampling Strategy

GRTR: Drug-Disease Association Prediction Based on Graph Regularized Transductive Regression on Heterogeneous Network

Drug Repurposing Therapeutics Prediction using Hierarchical Graph Neural Network.

An Effective Multi-Task Learning Framework for Drug Repurposing Based on Graph Representation Learning.

A computational drug repositioning model based on hybrid similarity side information powered graph neural network

Heterogeneous graph inference with matrix completion for computational drug repositioning

Computational drug repositioning with attention walking

A Multi-graph Deep Learning Model for Predicting Drug-Disease Associations.

Drug Repositioning Method Based on Deep Neural Network